Historical Volume

BLISS GVS PHARMA LTD.

NSE : BLISSGVSBSE : 506197ISIN CODE : INE416D01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE116.200.55 (+0.48 %)
PREV CLOSE ( ) 115.65
OPEN PRICE ( ) 115.80
BID PRICE (QTY) 115.90 (22)
OFFER PRICE (QTY) 116.15 (103)
VOLUME 9035
TODAY'S LOW / HIGH ( )115.30 116.50
52 WK LOW / HIGH ( )71 148.95
NSE115.70-0.1 (-0.09 %)
PREV CLOSE( ) 115.80
OPEN PRICE ( ) 115.80
BID PRICE (QTY) 115.70 (530)
OFFER PRICE (QTY) 115.95 (99)
VOLUME 111326
TODAY'S LOW / HIGH( ) 115.15 116.45
52 WK LOW / HIGH ( )70.85 149.6
Exchange
Period From  
Period To  
Date Open Price () High Price () Low Price () Close Price () Volume (000's) Turnover ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.